Search research articles
Contact Us
Filters
Showing results (51-60 of 59) with videos related to
Page
of 6
Sort By:
You have reached the last page of results.
This site can display upto 59 results.
Brachytherapy
|
December 30, 2022
Early outcomes of abbreviated multi-fractionated brachytherapy schedule for cervix cancer during COVID-19 pandemic
Supriya Chopra, Jaahid Mulani, Prachi Mittal, et al.
Oncoimmunology
|
June 27, 2022
PARP inhibition is a modulator of anti-tumor immune response in BRCA-deficient tumors
Anna D Staniszewska, Joshua Armenia, Matthew King, et al.
Cancer Immunology Research
|
August 28, 2019
Cyclophosphamide Enhances Cancer Antibody Immunotherapy in the Resistant Bone Marrow Niche by Modulating Macrophage FcγR Expression
Ali Roghanian, Guangan Hu, Christopher Fraser, et al.
Plos One
|
October 12, 2017
Dusp3 deletion in mice promotes experimental lung tumour metastasis in a macrophage dependent manner
Maud Vandereyken, Sophie Jacques, Eva Van Overmeire, et al.
International Journal of Radiation Oncology, Biology, Physics
|
October 1, 2024
Bladder Adjuvant Radiation Therapy (BART): Acute and Late Toxicity From a Phase III Multicenter Randomized Controlled Trial
Vedang Murthy, Priyamvada Maitre, Ganesh Bakshi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 18, 2020
<i>STAT3</i> Antisense Oligonucleotide Remodels the Suppressive Tumor Microenvironment to Enhance Immune Activation in Combination with Anti-PD-L1
Theresa A Proia, Maneesh Singh, Richard Woessner, et al.
Molecular Cancer Therapeutics
|
March 31, 2021
Macrophage Activation Status Rather than Repolarization Is Associated with Enhanced Checkpoint Activity in Combination with PI3Kγ Inhibition
Larissa S Carnevalli, Molly A Taylor, Matthew King, et al.
Breast (Edinburgh, Scotland)
|
March 25, 2022
Outcomes of non-metastatic triple negative breast cancers: Real-world data from a large Indian cohort
Jyoti Bajpai, Lakhan Kashyap, Dilip Harindran Vallathol, et al.
Journal for Immunotherapy of Cancer
|
April 7, 2022
Direct targeting of FOXP3 in Tregs with AZD8701, a novel antisense oligonucleotide to relieve immunosuppression in cancer
Alexey Revenko, Larissa S Carnevalli, Charles Sinclair, et al.
Page
of 6
Search research articles
Search
Showing results (51-60 of 59) with videos related to
Sort By:
Page
of 6
You have reached the last page of results.
This site can display upto 59 results.
Brachytherapy
|
December 30, 2022
Early outcomes of abbreviated multi-fractionated brachytherapy schedule for cervix cancer during COVID-19 pandemic
Supriya Chopra, Jaahid Mulani, Prachi Mittal, et al.
Oncoimmunology
|
June 27, 2022
PARP inhibition is a modulator of anti-tumor immune response in BRCA-deficient tumors
Anna D Staniszewska, Joshua Armenia, Matthew King, et al.
Cancer Immunology Research
|
August 28, 2019
Cyclophosphamide Enhances Cancer Antibody Immunotherapy in the Resistant Bone Marrow Niche by Modulating Macrophage FcγR Expression
Ali Roghanian, Guangan Hu, Christopher Fraser, et al.
Plos One
|
October 12, 2017
Dusp3 deletion in mice promotes experimental lung tumour metastasis in a macrophage dependent manner
Maud Vandereyken, Sophie Jacques, Eva Van Overmeire, et al.
International Journal of Radiation Oncology, Biology, Physics
|
October 1, 2024
Bladder Adjuvant Radiation Therapy (BART): Acute and Late Toxicity From a Phase III Multicenter Randomized Controlled Trial
Vedang Murthy, Priyamvada Maitre, Ganesh Bakshi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 18, 2020
<i>STAT3</i> Antisense Oligonucleotide Remodels the Suppressive Tumor Microenvironment to Enhance Immune Activation in Combination with Anti-PD-L1
Theresa A Proia, Maneesh Singh, Richard Woessner, et al.
Molecular Cancer Therapeutics
|
March 31, 2021
Macrophage Activation Status Rather than Repolarization Is Associated with Enhanced Checkpoint Activity in Combination with PI3Kγ Inhibition
Larissa S Carnevalli, Molly A Taylor, Matthew King, et al.
Breast (Edinburgh, Scotland)
|
March 25, 2022
Outcomes of non-metastatic triple negative breast cancers: Real-world data from a large Indian cohort
Jyoti Bajpai, Lakhan Kashyap, Dilip Harindran Vallathol, et al.
Journal for Immunotherapy of Cancer
|
April 7, 2022
Direct targeting of FOXP3 in Tregs with AZD8701, a novel antisense oligonucleotide to relieve immunosuppression in cancer
Alexey Revenko, Larissa S Carnevalli, Charles Sinclair, et al.
Page
of 6